Anti-GPR137B monoclonal antibody

Pre-made anti-GPR137B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GPR137B/GPR137B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0931-Ab-1/ GM-Tg-hg-IP0931-Ab-2Anti-Human GPR137B monoclonal antibodyHuman
GM-Tg-rg-IP0931-Ab-1/ GM-Tg-rg-IP0931-Ab-2Anti-Rat GPR137B monoclonal antibodyRat
GM-Tg-mg-IP0931-Ab-1/ GM-Tg-mg-IP0931-Ab-2Anti-Mouse GPR137B monoclonal antibodyMouse
GM-Tg-cynog-IP0931-Ab-1/ GM-Tg-cynog-IP0931-Ab-2Anti-Cynomolgus/ Rhesus macaque GPR137B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0931-Ab-1/ GM-Tg-felg-IP0931-Ab-2Anti-Feline GPR137B monoclonal antibodyFeline
GM-Tg-cang-IP0931-Ab-1/ GM-Tg-cang-IP0931-Ab-2Anti-Canine GPR137B monoclonal antibodyCanine
GM-Tg-bovg-IP0931-Ab-1/ GM-Tg-bovg-IP0931-Ab-2Anti-Bovine GPR137B monoclonal antibodyBovine
GM-Tg-equg-IP0931-Ab-1/ GM-Tg-equg-IP0931-Ab-2Anti-Equine GPR137B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0931-Ab-1/ GM-Tg-hg-IP0931-Ab-2; GM-Tg-rg-IP0931-Ab-1/ GM-Tg-rg-IP0931-Ab-2;
GM-Tg-mg-IP0931-Ab-1/ GM-Tg-mg-IP0931-Ab-2; GM-Tg-cynog-IP0931-Ab-1/ GM-Tg-cynog-IP0931-Ab-2;
GM-Tg-felg-IP0931-Ab-1/ GM-Tg-felg-IP0931-Ab-2; GM-Tg-cang-IP0931-Ab-1/ GM-Tg-cang-IP0931-Ab-2;
GM-Tg-bovg-IP0931-Ab-1/ GM-Tg-bovg-IP0931-Ab-2; GM-Tg-equg-IP0931-Ab-1/ GM-Tg-equg-IP0931-Ab-2
Products NameAnti-GPR137B monoclonal antibody
Formatmab
Target NameGPR137B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GPR137B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0931-Ag-1Recombinant multi-species G137B/ GPR137B/ ™7SF1 protein
    ORF Viral VectorvGMLP000098human GPR137B Lentivirus particle
    ORF Viral VectorpGMLP000098human GPR137B Lentivirus plasmid


    Target information

    Target IDGM-IP0931
    Target NameGPR137B
    Gene ID7107,83924,289287,717808,479194,101080918,613826,100050643
    Gene Symbol and SynonymsC730041E01,D13Abb1e,GPR137B,™7SF1
    Uniprot AccessionO60478
    Uniprot Entry NameG137B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000077585
    Target ClassificationGPCR

    The target: GPR137B, gene name: GPR137B, also named as ™7SF1. Involved in several processes, including positive regulation of TORC1 signaling; positive regulation of protein localization to lysosome; and regulation of GTPase activity. Located in lysosomal membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.